Jarmo S. Salonen

508 total citations
18 papers, 407 citations indexed

About

Jarmo S. Salonen is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Physiology. According to data from OpenAlex, Jarmo S. Salonen has authored 18 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 4 papers in Anesthesiology and Pain Medicine and 4 papers in Physiology. Recurrent topics in Jarmo S. Salonen's work include Pharmacogenetics and Drug Metabolism (11 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Anesthesia and Sedative Agents (4 papers). Jarmo S. Salonen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Anesthesia and Sedative Agents (4 papers). Jarmo S. Salonen collaborates with scholars based in Finland, United Kingdom and Sweden. Jarmo S. Salonen's co-authors include Leena Nyman, Olavi Pelkonen, Mats Hidestrand, Magnus Ingelman‐Sundberg, Päivi Taavitsainen, Jyrki Taskinen, Mikael Oscarson, Miia Turpeinen, Markku Anttila and Moshe Finel and has published in prestigious journals such as Analytical Biochemistry, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Jarmo S. Salonen

17 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jarmo S. Salonen Finland 11 212 95 92 71 54 18 407
T. W. Guentert Switzerland 15 157 0.7× 233 2.5× 95 1.0× 71 1.0× 56 1.0× 28 517
Satoru Kariya Japan 10 118 0.6× 214 2.3× 61 0.7× 83 1.2× 44 0.8× 25 519
A. Hayes United Kingdom 8 109 0.5× 133 1.4× 64 0.7× 162 2.3× 93 1.7× 15 599
Laurence Attolini France 12 104 0.5× 66 0.7× 39 0.4× 128 1.8× 26 0.5× 27 480
Henrik Björk Sweden 7 121 0.6× 233 2.5× 46 0.5× 99 1.4× 85 1.6× 12 681
Rita Labroo United States 11 156 0.7× 143 1.5× 73 0.8× 106 1.5× 63 1.2× 13 765
Philip A. Krieter United States 15 84 0.4× 157 1.7× 71 0.8× 175 2.5× 205 3.8× 21 792
Rustan Johansson Sweden 10 80 0.4× 111 1.2× 56 0.6× 67 0.9× 64 1.2× 17 471
Dafang Wu United States 8 211 1.0× 136 1.4× 75 0.8× 143 2.0× 97 1.8× 8 621
Tsun Chang United States 11 52 0.2× 104 1.1× 40 0.4× 120 1.7× 74 1.4× 22 472

Countries citing papers authored by Jarmo S. Salonen

Since Specialization
Citations

This map shows the geographic impact of Jarmo S. Salonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarmo S. Salonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarmo S. Salonen more than expected).

Fields of papers citing papers by Jarmo S. Salonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarmo S. Salonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarmo S. Salonen. The network helps show where Jarmo S. Salonen may publish in the future.

Co-authorship network of co-authors of Jarmo S. Salonen

This figure shows the co-authorship network connecting the top 25 collaborators of Jarmo S. Salonen. A scholar is included among the top collaborators of Jarmo S. Salonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarmo S. Salonen. Jarmo S. Salonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Leino, Tiina, Timo Viitamaa, Jarmo S. Salonen, Ullamari Pesonen, & Antti Haapalinna. (2021). Effects of fadolmidine, an α2‐adrenoceptor agonist, as an adjuvant to spinal bupivacaine on antinociception and motor function in rats and dogs. Pharmacology Research & Perspectives. 9(4). e00830–e00830. 2 indexed citations
2.
3.
Salonen, Jarmo S., Leena Nyman, Alan R. Boobis, et al.. (2003). COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS. Drug Metabolism and Disposition. 31(9). 1093–1102. 55 indexed citations
4.
Salonen, Jarmo S., et al.. (2002). N-Glucuronidation of Some 4-Arylalkyl-1H-Imidazoles by Rat, Dog, and Human Liver Microsomes. Drug Metabolism and Disposition. 30(3). 295–300. 21 indexed citations
5.
6.
Hidestrand, Mats, Mikael Oscarson, Jarmo S. Salonen, et al.. (2001). CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.. PubMed. 29(11). 1480–4. 77 indexed citations
7.
Taavitsainen, Päivi, et al.. (2000). Selegiline Metabolism and Cytochrome P450 Enzymes:In vitro Study in Human Liver Microsomes*. Pharmacology & Toxicology. 86(5). 215–221. 46 indexed citations
8.
Taavitsainen, Päivi, et al.. (2000). Selegiline Metabolism and Cytochrome P450 Enzymes:In vitro Study in Human Liver Microsomes*. Pharmacology & Toxicology. 86(5). 215–221. 10 indexed citations
9.
Haapalinna, Antti, Ewen MacDonald, Timo Viitamaa, et al.. (1999). Comparison of the effects of acute and subchronic administration of atipamezole on reaction to novelty and active avoidance learning in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 359(3). 194–203. 18 indexed citations
10.
MacDonald, Ewen, et al.. (1993). Systemic absorption and systemic effects of ocularly administered dexmedetomidine in rabbits. Current Eye Research. 12(5). 451–460.
11.
Jäkälä, Pekka, Timo Viitamaa, Jouni Sirviö, et al.. (1992). Continuous α2-adrenoceptor blockade by atipamezole decreases neocortical high-voltage spindle activity in rats. European Journal of Pharmacology. 221(2-3). 351–357. 10 indexed citations
12.
Salonen, Jarmo S.. (1991). Tissue‐Specificity of Hydroxylation and N‐Methylation of Arylalkylimidazoles. Pharmacology & Toxicology. 69(1). 1–4. 23 indexed citations
13.
Salonen, Jarmo S.. (1990). Determination of the amine metabolites of selegiline in biological fluids by capillary gas chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 527(1). 163–168. 20 indexed citations
14.
Salonen, Jarmo S., et al.. (1990). Biotransformation of medetomidine in the rat. Xenobiotica. 20(5). 471–480. 29 indexed citations
15.
Salonen, Jarmo S., et al.. (1988). Metabolism of detomidine in the rat II. Characterisation of metabolites in urine. European Journal of Drug Metabolism and Pharmacokinetics. 13(1). 59–65. 8 indexed citations
16.
Salonen, Jarmo S., et al.. (1988). Metabolism of detomidine in the rat. I. Comparison of3H-labelled metabolites formed in vitro and in vivo. European Journal of Drug Metabolism and Pharmacokinetics. 13(1). 53–58. 8 indexed citations
17.
Vakkuri, Olli, et al.. (1987). Radioimmunoassay of detomidine, a new benzylimidazole drug with analgesic sedation properties. Life Sciences. 40(14). 1357–1364. 6 indexed citations
18.
Salonen, Jarmo S. & Mika Scheinin. (1983). Determination of Maprotiline and N-Desmethylmaprotiline from Biological Fluids by HPLC. Journal of Analytical Toxicology. 7(4). 175–177. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. W. Guentert Breakdown of academic impact, for papers by Satoru Kariya Breakdown of academic impact, for papers by A. Hayes Breakdown of academic impact, for papers by Laurence Attolini Breakdown of academic impact, for papers by Henrik Björk Breakdown of academic impact, for papers by Rita Labroo Breakdown of academic impact, for papers by Philip A. Krieter Breakdown of academic impact, for papers by Rustan Johansson Breakdown of academic impact, for papers by Dafang Wu Breakdown of academic impact, for papers by Tsun Chang
Rankless by CCL
2026